Literature DB >> 23815589

Identification and analysis of conserved pockets on protein surfaces.

Marco Cammisa1, Antonella Correra, Giuseppina Andreotti, Maria Vittoria Cubellis.   

Abstract

BACKGROUND: The interaction between proteins and ligands occurs at pockets that are often lined by conserved amino acids. These pockets can represent the targets for low molecular weight drugs. In order to make the research for new medicines as productive as possible, it is necessary to exploit "in silico" techniques, high throughput and fragment-based screenings that require the identification of druggable pockets on the surface of proteins, which may or may not correspond to active sites.
RESULTS: We developed a tool to evaluate the conservation of each pocket detected on the protein surface by CastP. This tool was named DrosteP because it recursively searches for optimal input sequences to be used to calculate conservation. DrosteP uses a descriptor of statistical significance, Poisson p-value, as a target to optimize the choice of input sequences. To benchmark DrosteP we used monomeric or homodimer human proteins with known 3D-structure whose active site had been annotated in UniProt. DrosteP is able to detect the active site with high accuracy because in 81% of the cases it coincides with the most conserved pocket. Comparing DrosteP with analogous programs is difficult because the outputs are different. Nonetheless we could assess the efficacy of the recursive algorithm in the identification of active site pockets by calculating conservation with the same input sequences used by other programs.We analyzed the amino-acid composition of conserved pockets identified by DrosteP and we found that it differs significantly from the amino-acid composition of non conserved pockets.
CONCLUSIONS: Several methods for predicting ligand binding sites on protein surfaces, that combine 3D-structure and evolutionary sequence conservation, have been proposed. Any method relying on conservation mainly depends on the choice of the input sequences. DrosteP chooses how deeply distant homologs must be collected to evaluate conservation and thus optimizes the identification of active site pockets. Moreover it recognizes conserved pockets other than those coinciding with the sites annotated in UniProt that might represent useful druggable sites. The distinctive amino-acid composition of conserved pockets provides useful hints on the fundamental principles underlying protein-ligand interaction. AVAILABILITY: http://www.icb.cnr.it/project/drosteppy/

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23815589      PMCID: PMC3633052          DOI: 10.1186/1471-2105-14-S7-S9

Source DB:  PubMed          Journal:  BMC Bioinformatics        ISSN: 1471-2105            Impact factor:   3.169


  26 in total

1.  EMBOSS: the European Molecular Biology Open Software Suite.

Authors:  P Rice; I Longden; A Bleasby
Journal:  Trends Genet       Date:  2000-06       Impact factor: 11.639

Review 2.  Aromatic interactions in model systems.

Authors:  Marcey L Waters
Journal:  Curr Opin Chem Biol       Date:  2002-12       Impact factor: 8.822

3.  Distinguishing structural and functional restraints in evolution in order to identify interaction sites.

Authors:  Vijayalakshmi Chelliah; Lan Chen; Tom L Blundell; Simon C Lovell
Journal:  J Mol Biol       Date:  2004-10-01       Impact factor: 5.469

Review 4.  Mucopolysaccharidosis type VI: Structural and clinical implications of mutations in N-acetylgalactosamine-4-sulfatase.

Authors:  T Litjens; J J Hopwood
Journal:  Hum Mutat       Date:  2001-10       Impact factor: 4.878

5.  Anatomy of protein pockets and cavities: measurement of binding site geometry and implications for ligand design.

Authors:  J Liang; H Edelsbrunner; C Woodward
Journal:  Protein Sci       Date:  1998-09       Impact factor: 6.725

6.  Protein clefts in molecular recognition and function.

Authors:  R A Laskowski; N M Luscombe; M B Swindells; J M Thornton
Journal:  Protein Sci       Date:  1996-12       Impact factor: 6.725

7.  Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure.

Authors:  R L DesJarlais; R P Sheridan; G L Seibel; J S Dixon; I D Kuntz; R Venkataraghavan
Journal:  J Med Chem       Date:  1988-04       Impact factor: 7.446

8.  SURFNET: a program for visualizing molecular surfaces, cavities, and intermolecular interactions.

Authors:  R A Laskowski
Journal:  J Mol Graph       Date:  1995-10

9.  Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): a Y210C mutation causes either altered protein handling or altered protein function of N-acetylgalactosamine 4-sulfatase at multiple points in the vacuolar network.

Authors:  Tessa M Bradford; Tom Litjens; Emma J Parkinson; John J Hopwood; Doug A Brooks
Journal:  Biochemistry       Date:  2002-04-16       Impact factor: 3.162

10.  Identification of binding pockets in protein structures using a knowledge-based potential derived from local structural similarities.

Authors:  Valerio Bianchi; Pier Federico Gherardini; Manuela Helmer-Citterich; Gabriele Ausiello
Journal:  BMC Bioinformatics       Date:  2012-03-28       Impact factor: 3.169

View more
  14 in total

1.  Elucidating the druggability of the human proteome with eFindSite.

Authors:  Omar Kana; Michal Brylinski
Journal:  J Comput Aided Mol Des       Date:  2019-03-19       Impact factor: 3.686

2.  Functional characterisation of a novel mutation affecting the catalytic domain of MMP2 in siblings with multicentric osteolysis, nodulosis and arthropathy.

Authors:  Jacopo Azzollini; Davide Rovina; Cristina Gervasini; Ilaria Parenti; Alessia Fratoni; Maria Vittoria Cubellis; Amilcare Cerri; Luca Pietrogrande; Lidia Larizza
Journal:  J Hum Genet       Date:  2014-10-02       Impact factor: 3.172

3.  Taming molecular flexibility to tackle rare diseases.

Authors:  Maria Vittoria Cubellis; Marc Baaden; Giuseppina Andreotti
Journal:  Biochimie       Date:  2015-04-02       Impact factor: 4.079

4.  Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones.

Authors:  Marco Cammisa; Antonella Correra; Giuseppina Andreotti; Maria Vittoria Cubellis
Journal:  Orphanet J Rare Dis       Date:  2013-07-24       Impact factor: 4.123

5.  Conformational response to ligand binding in phosphomannomutase2: insights into inborn glycosylation disorder.

Authors:  Giuseppina Andreotti; Israel Cabeza de Vaca; Angelita Poziello; Maria Chiara Monti; Victor Guallar; Maria Vittoria Cubellis
Journal:  J Biol Chem       Date:  2014-10-16       Impact factor: 5.157

6.  Identification of an Allosteric Binding Site on Human Lysosomal Alpha-Galactosidase Opens the Way to New Pharmacological Chaperones for Fabry Disease.

Authors:  Valentina Citro; Jorge Peña-García; Helena den-Haan; Horacio Pérez-Sánchez; Rosita Del Prete; Ludovica Liguori; Chiara Cimmaruta; Jan Lukas; Maria Vittoria Cubellis; Giuseppina Andreotti
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

Review 7.  The Large Phenotypic Spectrum of Fabry Disease Requires Graduated Diagnosis and Personalized Therapy: A Meta-Analysis Can Help to Differentiate Missense Mutations.

Authors:  Valentina Citro; Marco Cammisa; Ludovica Liguori; Chiara Cimmaruta; Jan Lukas; Maria Vittoria Cubellis; Giuseppina Andreotti
Journal:  Int J Mol Sci       Date:  2016-12-01       Impact factor: 5.923

8.  Computational Modeling of the Staphylococcal Enterotoxins and Their Interaction with Natural Antitoxin Compounds

Authors:  Mahantesh Kurjogi; Praveen Satapute; Sudisha Jogaiah; Mostafa Abdelrahman; Jayasimha Rayalu Daddam; Venkatesh Ramu; Lam-Son Phan Tran
Journal:  Int J Mol Sci       Date:  2018-01-03       Impact factor: 5.923

9.  Bioinformatics in Italy: BITS 2012, the ninth annual meeting of the Italian Society of Bioinformatics.

Authors:  Carmela Gissi; Paolo Romano; Alfredo Ferro; Rosalba Giugno; Alfredo Pulvirenti; Angelo Facchiano; Manuela Helmer-Citterich
Journal:  BMC Bioinformatics       Date:  2013-04-22       Impact factor: 3.169

10.  A thermodynamic assay to test pharmacological chaperones for Fabry disease.

Authors:  Giuseppina Andreotti; Valentina Citro; Antonella Correra; Maria Vittoria Cubellis
Journal:  Biochim Biophys Acta       Date:  2013-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.